About US
Contact us
-
NMRC and WRAIR develop personalised phage cocktails to treat antibiotic-resistant infectionA team from US Naval Medical Research Centre (NMRC) and Maryland’s Walter Reed Army Institute of Research (WRAIR) has been successful in using bacteriophage therapy to fight an antibiotic-resistant in2016/8/11
-
UPDATED: California snares $30M in Bristol-Myers kickbacks case featuring luxury golf, lavish dinners and Lakers campGolf outings at top courses. Box suites at sporting events. A Los Angeles Lakers basketball camp. And the usual “lavish dinners.” They all figured into a California crackdown on Bristol-Myers Squibb’s2016/8/10
-
Shareholders sue struggling Perrigo for 'misleading' them away from Mylan buySince dodging a hostile buyout attempt from generics maker Mylan, Perrigo hasn’t been doing so hot. And some of the company’s shareholders aren’t pleased. Investors have filed a class action lawsuit2016/8/10
-
New research reveals alcohol abuse control drug can treat blinding disorderNew research has revealed that the drug known asdisulfiram, which is licensed for the control of alcohol abuse, can be used to prevent conjunctival scarring and treat a blinding disorder. Disulfiram2016/8/9
-
ScinoPharm and CVie to develop new heart failure treatmentScinoPharm Taiwan, in collaboration with pharmaceutical products manufacturer CVie Therapeutics, has launched a discovery and development collaboration to identify the new generation compound to heart2016/8/9
-
Deals this week: Orgenesis, Advanced Accelerator Applications, Kyowa PharmaceuticalOrgenesis INChas formed a joint venture (JV) with Atvio Biotech to provide gene and cell therapy development services. According to the agreement, Orgenesis and shareholders of Atvio hold a 50-50 par2016/8/8
-
Genetic testing of rare form of tumour can reveal cancer chances in familiesA new study has revealed that genetic testing of patients with a rare form of cancer can pick out genetic errors hidden in their family that increases the risk of a wide range of cancer types. Geneti2016/8/8
-
M&As this week: Teva Pharmaceutical Industries Ltd, Epic Health ServicesTeva Pharmaceutical Industries Ltdhas entered a definitive agreement to acquire Anda Inc. from Allergan plc for a purchase consideration of $500m. According to the agreement, Teva will acquire three2016/8/5
-
Novartis’ LEE011 breast cancer treatment receives FDA Breakthrough Therapy designationThe US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Swiss-based healthcare company Novartis’ LEE011 (ribociclib) in combination with letrozole for the treatment o2016/8/5
-
AstraZeneca's bid to protect Crestor fails as judge refuses to block new genericsThe Crestor generics are coming. AstraZeneca failed its last-ditch attempt to protect the blockbuster brand Tuesday, when a federal judge denied its bid for a restraining order. AstraZeneca had argue2016/8/4